| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 272.14B | 270.97B | 252.86B | 232.05B | 219.62B | 215.68B |
| Gross Profit | 41.73B | 40.48B | 37.41B | 32.32B | 34.90B | 35.54B |
| EBITDA | 29.17B | 28.82B | 27.40B | 8.28B | 23.38B | 23.55B |
| Net Income | 10.90B | 10.76B | 9.35B | -5.55B | 8.28B | 8.83B |
Balance Sheet | ||||||
| Total Assets | 292.95B | 315.28B | 310.57B | 305.22B | 306.59B | 312.92B |
| Cash, Cash Equivalents and Short-Term Investments | 40.20B | 43.03B | 39.78B | 31.80B | 30.52B | 48.41B |
| Total Debt | 81.40B | 91.17B | 93.02B | 97.06B | 98.98B | 109.11B |
| Total Liabilities | 157.46B | 178.60B | 179.43B | 188.03B | 179.99B | 193.17B |
| Stockholders Equity | 135.45B | 136.63B | 131.10B | 117.16B | 126.57B | 119.72B |
Cash Flow | ||||||
| Free Cash Flow | 2.48B | 11.62B | 14.44B | 9.02B | -455.00M | 17.85B |
| Operating Cash Flow | 3.72B | 17.77B | 17.75B | 11.40B | 4.52B | 22.67B |
| Investing Cash Flow | -806.00M | -3.72B | -2.64B | -3.01B | 2.29B | -4.20B |
| Financing Cash Flow | -4.62B | -11.79B | -7.95B | -6.23B | -25.42B | -8.01B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
82 Outperform | ¥145.56B | 9.06 | ― | 3.22% | 12.23% | 43.29% | |
76 Outperform | ¥259.31B | 12.19 | 7.43% | 2.78% | 1.31% | 59.20% | |
76 Outperform | ¥96.56B | 13.41 | ― | 4.38% | -0.84% | -1.80% | |
71 Outperform | ¥184.07B | 9.99 | ― | 2.87% | 6.66% | 46.38% | |
70 Outperform | ¥127.11B | 9.59 | ― | 1.55% | 20.44% | 106.45% | |
66 Neutral | ¥199.22B | 12.14 | ― | 3.09% | 3.75% | 87.00% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% |